Updated recommendations for the design of therapeutic trials for neonatal seizures
View abstract on PubMed
Summary
This summary is machine-generated.Updated guidelines for neonatal seizure clinical trials emphasize exploring new efficacy endpoints and improving patient recruitment. These recommendations aim to enhance trial design and feasibility for treating neonatal seizures effectively.
Area Of Science
- Neonatal Neurology
- Clinical Trial Design
- Pharmacology
Background
- Neonatal seizures pose significant challenges in clinical management and research.
- Previous recommendations for neonatal seizure trial design require updates based on recent experiences.
Purpose Of The Study
- To provide updated recommendations for the design of clinical trials investigating treatments for neonatal seizures.
- To address challenges in efficacy endpoint definition, recruitment, and operational feasibility.
Main Methods
- Review of recent clinical trial experiences and developments in neonatal seizure treatment.
- Formulation of updated recommendations by the International Neonatal Consortium Seizure Working Group.
Main Results
- Recommendations for including alternate seizure burden reduction measures as exploratory endpoints.
- Inclusion of key covariates like seizure timing, randomization, and anti-seizure medication (ASM) administration.
- Guidance on trial masking, reporting of concomitant medications, adverse events, and genetic testing.
- Strategies for improved recruitment and consent, including novel technologies and patient advocacy group involvement.
- Considerations for trial infrastructure, operational feasibility, and regulatory accommodations.
Conclusions
- Updated recommendations aim to refine neonatal seizure trial design for greater clinical meaningfulness and feasibility.
- Emphasis on exploratory endpoints, robust covariate inclusion, and enhanced recruitment strategies.
- Adaptability to local regulations and resources is crucial for successful trial conduct.
Related Concept Videos
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Focal aware seizures: In these seizures, the person remains conscious...
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

